Page 8 - பிரஞ்சு தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. Eyevensys Named to French Tech 120 Program February 15, 2021 GMT PARIS & CAMBRIDGE, Mass. (BUSINESS WIRE) Feb 15, 2021 Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021. This government-backed program, run by La French Tech, offers support for 120 French startups considered late-stage and in a hypergrowth phase. Participating companies benefit from a variety of initiatives designed to support the needs of companies in this stage, such as unlimited access to government, public and ministry services, as well as tailored services from partner agencies. Participants will also benefit from collaboration with the French Tech 120 community, and a needs analysis that will help shape future regulations.

United kingdomFrance generalUnited statesFrancine behar cohenPureos bioventuresPatricia zillioxMarion janicGlobal health sciences fundInserm transfert initiativeEuropean medicines agencyInnobio fundBoehringer ingelheim venture fundFrench techElectrotransfection systemChief innovation officerTherapy showcase